| Revision as of 01:27, 4 November 2013 editSandyGeorgia (talk | contribs)Autopatrolled, Extended confirmed users, Page movers, File movers, Mass message senders, New page reviewers, Pending changes reviewers, Rollbackers, Template editors279,026 edits cite← Previous edit | Revision as of 01:30, 4 November 2013 edit undoSandyGeorgia (talk | contribs)Autopatrolled, Extended confirmed users, Page movers, File movers, Mass message senders, New page reviewers, Pending changes reviewers, Rollbackers, Template editors279,026 edits →Scientific Work: profNext edit → | ||
| Line 46: | Line 46: | ||
| Pichichero received his undergraduate degree from ], and his medical degree from the ].<ref name=Legacy/> | Pichichero received his undergraduate degree from ], and his medical degree from the ].<ref name=Legacy/> | ||
| == |
==Professional== | ||
| Pichero's studies say that ethylmercury, the metabolite of thimerosal, is rapidly metabolized and excreted after administration of TCVs, as well as that administration thereof does not raise blood mercury levels above the ]'s lower limit. In addition, his research has concluded that ethylmercury is metabolized about six times as fast as ] (the kind of mercury found in fish).<ref>{{cite web | url=http://www.medscape.com/viewarticle/445538 | title=Mercury in Vaccines: A Newsmaker Interview With Michael E. Pichichero, MD | publisher=] | date=3 December 2002 | accessdate=31 August 2013 | author=Barclay, Laurie}}</ref> His research says that after children receive a vaccine with thimerosal in it, their blood mercury levels return to normal within only a month.<ref>{{cite web | url=http://usatoday30.usatoday.com/news/health/2008-01-31-vaccines-mercury_N.htm | title=Study: Mercury fades quickly from blood | work=] | date=31 January 2008 | accessdate=31 August 2013 | author=Johnson, Carla K.}}</ref> | Pichero's studies say that ethylmercury, the metabolite of thimerosal, is rapidly metabolized and excreted after administration of TCVs, as well as that administration thereof does not raise blood mercury levels above the ]'s lower limit. In addition, his research has concluded that ethylmercury is metabolized about six times as fast as ] (the kind of mercury found in fish).<ref>{{cite web | url=http://www.medscape.com/viewarticle/445538 | title=Mercury in Vaccines: A Newsmaker Interview With Michael E. Pichichero, MD | publisher=] | date=3 December 2002 | accessdate=31 August 2013 | author=Barclay, Laurie}}</ref> His research says that after children receive a vaccine with thimerosal in it, their blood mercury levels return to normal within only a month.<ref>{{cite web | url=http://usatoday30.usatoday.com/news/health/2008-01-31-vaccines-mercury_N.htm | title=Study: Mercury fades quickly from blood | work=] | date=31 January 2008 | accessdate=31 August 2013 | author=Johnson, Carla K.}}</ref> | ||
Revision as of 01:30, 4 November 2013
| Michael E. Pichichero | |
|---|---|
| Alma mater | University of Rochester School of Medicine |
| Known for | Thimerosal controversy |
| Awards | Breese Award for Outstanding Contribution to Clinical Research, Teaching and Practice, 2005 |
| Scientific career | |
| Fields | Pediatrics, toxicology |
| Institutions | University of Rochester Medical Center |
Michael E. Pichichero, MD is a clinical professor in the Department of Pediatrics at the University of Rochester Medical Center. He is the author of a number of scientific studies regarding the safety of thimerosal as a preservative in vaccines.
Biography
Pichichero received his undergraduate degree from Rutgers University, and his medical degree from the University of Rochester.
Professional
Pichero's studies say that ethylmercury, the metabolite of thimerosal, is rapidly metabolized and excreted after administration of TCVs, as well as that administration thereof does not raise blood mercury levels above the EPA's lower limit. In addition, his research has concluded that ethylmercury is metabolized about six times as fast as methylmercury (the kind of mercury found in fish). His research says that after children receive a vaccine with thimerosal in it, their blood mercury levels return to normal within only a month.
Pichichero has written a textbook about streptococcal pharyngitis. A board-certified immunologist, he was on the team of scientists at the University of Rochester who invented the Hib vaccine. His more recent research, however, has focused on otitis media, as well as a syndrome his lab discovered and termed, "PNIP (Prolonged Neonatal Immune Profile)".
Selected publications
- Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9470015, please use {{cite journal}} with
|pmid=9470015instead. - Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15805383, please use {{cite journal}} with
|pmid=15805383instead. - Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20335823, please use {{cite journal}} with
|pmid=20335823instead.
References
- ^ "Meet our Doctors". Legacy Pediatrics. Retrieved 31 August 2013.
- "Michael E. Pichichero". University of Rochester Medical Center. Retrieved 31 August 2013.
- Barclay, Laurie (3 December 2002). "Mercury in Vaccines: A Newsmaker Interview With Michael E. Pichichero, MD". Medscape. Retrieved 31 August 2013.
- Johnson, Carla K. (31 January 2008). "Study: Mercury fades quickly from blood". USA Today. Retrieved 31 August 2013.
- Pichichero, Michael (2007). Clinical Management of Streptococcal Pharyngitis. Professional Communications.
- ^ "Our Researchers". Rochester General Health System. Retrieved 31 August 2013.
External links
- Mercury in Childhood Vaccines Excreted Quickly
- Mercury in Childhood Vaccines Excreted Quickly
- Babies excrete vaccine-mercury quicker than originally thought
 | This biographical article about a scientist is a stub. You can help Misplaced Pages by expanding it. |